DISCONTINUED OPERATIONS (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014	Nov. 25, 2015	Sep. 08, 2015
Included in assets held for sale | Genetic Assays and Platforms and Patient Testing
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
(Loss) gain on sale of business			$ (224)	$ 4,114
Edge BioSystems, Inc | Genetic Assays And Platforms Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Consideration received on assets disposal						$ 2,100
(Loss) gain on sale of business			1,500
Edge BioSystems, Inc | Included in assets held for sale | Genetic Assays And Platforms Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
(Loss) gain on sale of business		$ 1,500
ADSTEC Corporation | Genetic Assays And Platforms Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Consideration received on assets disposal					$ 300
(Loss) gain on sale of business			$ (1,700)
ADSTEC Corporation | Included in assets held for sale | Genetic Assays And Platforms Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
(Loss) gain on sale of business	$ (1,700)